MedTrace Logo

Nesiritide for Ventilated Congestive Heart Failure

NCT04455477 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2020-07-02

No results posted yet for this study

Summary

The congestive heart failure is a common disease among patients who receive cardiac surgery and may lead to prolonged ventilation support. Nesiritide was a potential therapy for congestive heart failure. This study aimed to compare the Nesiritide induced hemodynamical status changes among congestive heart failure patients with invasive ventilation support.

Conditions

  • Congestive Heart Failure
  • Mechanical Ventilation
  • Using Nesiritide
  • Venous Return
  • Cardiac Function

Interventions

DRUG

Nesiritide

The attending physicans decide whether to use Nesiritide for congestive heart failure patients. Only patients who will use Nesiritide are enrolled.

Sponsors & Collaborators

  • Shanghai Zhongshan Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-14
Primary Completion
2021-12-31
Completion
2021-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04455477 on ClinicalTrials.gov